Literature DB >> 14735588

Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy.

Paolo Moretti1, Maria Blazo, Leonardo Garcia, Dawna Armstrong, Richard Alan Lewis, Benjamin Roa, Fernando Scaglia.   

Abstract

An 11-year-old boy was evaluated for progressive ataxia, cognitive deterioration, and ophthalmoplegia. The child initially presented with abnormal eye movements at the age of 2 months and was noted to have developmental delay at 6 months. At the age of 7 years, he developed ataxia and cognitive impairment, and subsequently manifested dysphagia and incontinence. The pertinent family history included gait difficulty in the paternal grandmother. At the age of 11, his general physical examination was normal. On neurological examination, he had bilateral external ophthalmoplegia, ataxic dysarthria, dysmetria and tremor in the upper extremities, and marked gait ataxia. An ophthalmological evaluation showed no evidence of pigmentary retinopathy. Brain MRI demonstrated cerebellar, brainstem, and cerebral atrophy. An ataxia panel showed 62 repeats in one allele of the SCA2 gene. Most cases of spinocerebellar ataxia type 2 (SCA2) present between 20 years and 40 years, and affected individuals typically have between 34 and 57 CAG repeats. Neonatal cases of SCA2 have been reported in individuals with over 200 CAG repeats. Childhood SCA2 has been reported previously in two patients but not described clinically. This case broadens the spectrum of the clinical features of infantile-onset SCA2 and highlights the importance of considering this diagnosis in infants and children. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14735588     DOI: 10.1002/ajmg.a.20428

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  Large pathogenic expansions in the SCA2 and SCA7 genes can be detected by fluorescent repeat-primed polymerase chain reaction assay.

Authors:  Claudia Cagnoli; Giovanni Stevanin; Chiara Michielotto; Giovanni Gerbino Promis; Alessandro Brussino; Patrizia Pappi; Alexandra Durr; Elisa Dragone; Michelle Viemont; Cinzia Gellera; Alexis Brice; Nicola Migone; Alfredo Brusco
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

2.  Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms.

Authors:  A R Paciorkowski; Y Shafrir; J Hrivnak; M C Patterson; M B Tennison; H B Clark; C M Gomez
Journal:  Neurology       Date:  2011-08-31       Impact factor: 9.910

Review 3.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

4.  MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2.

Authors:  Brian C Jung; Soo I Choi; Annie X Du; Jennifer L Cuzzocreo; Howard S Ying; Bennett A Landman; Susan L Perlman; Robert W Baloh; David S Zee; Arthur W Toga; Jerry L Prince; Sarah H Ying
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

5.  Infantile childhood onset of spinocerebellar ataxia type 2.

Authors:  Roberto Di Fabio; Filippo Santorelli; Enrico Bertini; Martina Balestri; Laura Cursi; Alessandra Tessa; Francesco Pierelli; Carlo Casali
Journal:  Cerebellum       Date:  2012-06       Impact factor: 3.847

6.  Spinocerebellar ataxia type 2 presenting with cognitive regression in childhood.

Authors:  Melissa B Ramocki; Lynn Chapieski; Ryan O McDonald; Fabio Fernandez; Amy D Malphrus
Journal:  J Child Neurol       Date:  2008-03-14       Impact factor: 1.987

7.  Spinocerebellar ataxia type 2 (SCA2) in an Egyptian family presenting with polyphagia and marked CAG expansion in infancy.

Authors:  Alice Abdel-Aleem; Maha S Zaki
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

8.  Two young sisters with spinocerebellar ataxia type 2 showing different clinical progression of disease.

Authors:  Uluç Yiş; Eray Dirik; Semra Hiz Kurul; Asli Gündoğdu Eken; A Nazli Başak
Journal:  Cerebellum       Date:  2008-11-21       Impact factor: 3.847

Review 9.  Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data.

Authors:  Karolina Świtońska-Kurkowska; Bart Krist; Joanna Delimata; Maciej Figiel
Journal:  Front Cell Dev Biol       Date:  2021-07-01

Review 10.  Cognition in hereditary ataxia.

Authors:  Katrin Bürk
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.